<?xml version="1.0" encoding="UTF-8"?>
<p>We further showed that 
 <italic>S. baicalensis</italic> extract, baicalein, and the four active baicalein analogue compounds also inhibit the activity of SARS-CoV 3CL
 <sup>pro</sup>
 <italic>in vitro</italic> (
 <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/14756366.2021.1873977" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S3</ext-link>), demonstrating their potential as broad spectrum anti-CoV agents. For future development and 
 <italic>in vivo</italic> studies, the bioavailability of these compounds needs to be considered. Although the bioavailability of baicalein is low in oral administration, its concentration can be increased at lung tissue through intratracheal administration
 <xref rid="CIT0030" ref-type="bibr">
  <sup>30</sup>
 </xref>. We suggest that these compounds can be further optimised or used to search for other TCM herbs containing these compounds or substructures to develop effective treatments for COVID-19 and other coronavirus infectious diseases.
</p>
